This company has so much going for it
1 Located in a massively growing market - Asia
2 Revenue around $20million
3 Pays a dividend
4 No debt
5 Plenty of cash
6 New CEO
7 Opportunity to utilize AI to streamline the business model
8 Massive opportunity to cut the $9,000,000 wage expenditure
9 The company could be producing substantial profit with astute restructuring
10 Rebrand the rediculous names they applied to their acquisitions. Find somebody who can connect the marketing of these products to potential customers.
11. The Board is now making decisions relevant to changing the "safety" zone mentality and building a business model using a sound calculated risk approach.
Investors have this company on the radar and are waiting to push the button
- Forums
- ASX - By Stock
- Ann: Appointment of CEO
This company has so much going for it 1 Located in a massively...
Featured News
Add JCS (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.8¢ |
Change
-0.002(6.67%) |
Mkt cap ! $9.249M |
Open | High | Low | Value | Volume |
2.8¢ | 2.8¢ | 2.8¢ | $560 | 20K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 25000 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.8¢ | 280000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 25000 | 0.026 |
1 | 225000 | 0.021 |
1 | 200000 | 0.016 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.028 | 280000 | 1 |
0.030 | 4041802 | 5 |
0.031 | 267000 | 1 |
0.034 | 104000 | 1 |
0.036 | 272846 | 2 |
Last trade - 13.04pm 13/11/2024 (20 minute delay) ? |
Featured News
JCS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online